First Trust Advisors’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

First Trust Advisors’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-50,950	Closed	-$620K	–	2457
2016 Q1	$620K	Buy	+50,950	New	+$714K	﹤0.01%	1858
2015 Q4	–	Sell	-27,441	Closed	-$421K	–	2358
2015 Q3	$421K	Buy	+27,441	New	+$593K	﹤0.01%	2010
2015 Q1	–	Sell	-87,476	Closed	-$2.2M	–	2352
2014 Q4	$2.2M	Buy	87,476 +80,877	+1,226%	+$2.37M	0.01%	1399
2014 Q3	$205K	Buy	+6,599	New	+$179K	﹤0.01%	2131
2014 Q2	–	Sell	-9,323	Closed	-$218K	–	2353
2014 Q1	$218K	Buy	+9,323	New	+$204K	﹤0.01%	2154

Other funds holding SGNT

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First Trust Advisors's SGNT Position: Q2 2016 in Review

First Trust Advisors sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q2 2016, closing a stake of 50,950 shares — an estimated $620K sold.

First Trust Advisors first reported a position in SGNT in Q1 2014 and held it in 5 quarters. The position peaked at $2.2M in Q4 2014. 128 funds tracked by Wall St. Rank hold SGNT as of Q2 2016.

First Trust Advisors reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
First Trust Advisors sold 50,950 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q2 2016, an estimated $620K.
First Trust Advisors first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
First Trust Advisors's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $2.2M in Q4 2014.
128 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q2 2016.

Based on First Trust Advisors's 13F filing for Q2 2016, filed 4 Aug 2016.